A detailed history of A. D. Beadell Investment Counsel, Inc. transactions in Stryker Corp stock. As of the latest transaction made, A. D. Beadell Investment Counsel, Inc. holds 4,250 shares of SYK stock, worth $1.55 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares
4,250
Previous 4,250 -0.0%
Holding current value
$1.55 Million
Previous $1.45 Million 6.15%
% of portfolio
1.23%
Previous 1.21%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$324.3 - $354.67 $64,860 - $70,934
-200 Reduced 4.49%
4,250 $1.45 Million
Q2 2023

Jul 13, 2023

SELL
$271.49 - $305.09 $118,098 - $132,714
-435 Reduced 8.9%
4,450 $1.36 Million
Q1 2023

Apr 12, 2023

SELL
$246.13 - $285.47 $24,613 - $28,547
-100 Reduced 2.01%
4,885 $1.39 Million
Q3 2022

Oct 13, 2022

BUY
$189.27 - $231.83 $75,708 - $92,732
400 Added 8.72%
4,985 $1.01 Million
Q2 2022

Jul 15, 2022

SELL
$194.09 - $276.37 $77,636 - $110,548
-400 Reduced 8.02%
4,585 $912,000
Q4 2020

Jan 15, 2021

SELL
$202.01 - $245.04 $5,050 - $6,126
-25 Reduced 0.5%
4,985 $1.22 Million
Q3 2020

Nov 02, 2020

BUY
$177.77 - $215.81 $2,666 - $3,237
15 Added 0.3%
5,010 $1.04 Million
Q2 2020

Jul 15, 2020

SELL
$144.67 - $207.03 $2,170 - $3,105
-15 Reduced 0.3%
4,995 $900,000
Q1 2020

Apr 22, 2020

BUY
$126.5 - $225.1 $12,650 - $22,510
100 Added 2.04%
5,010 $834,000
Q4 2019

Feb 04, 2020

BUY
$197.98 - $220.53 $4,949 - $5,513
25 Added 0.51%
4,910 $1.03 Million
Q3 2018

Oct 23, 2018

SELL
$163.25 - $177.68 $81,625 - $88,840
-500 Reduced 9.29%
4,885 $867,000
Q4 2017

Feb 06, 2018

BUY
$143.51 - $159.74 $48,075 - $53,512
335 Added 6.63%
5,385 $833,000
Q3 2017

Oct 25, 2017

BUY
$138.36 - $147.87 $698,718 - $746,743
5,050
5,050 $717,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $138B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track A. D. Beadell Investment Counsel, Inc. Portfolio

Follow A. D. Beadell Investment Counsel, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of A. D. Beadell Investment Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on A. D. Beadell Investment Counsel, Inc. with notifications on news.